These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18816247)

  • 1. IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome.
    Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Mälarstig A; Brismar K; Hamsten A; Fisher RM; Hellénius ML
    Clin Sci (Lond); 2009 Mar; 116(6):507-12. PubMed ID: 18816247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
    Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
    Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W
    Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease.
    Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
    Scand J Clin Lab Invest; 2007; 67(5):553-9. PubMed ID: 17763192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.
    Hunt KJ; Lukanova A; Rinaldi S; Lundin E; Norat T; Palmqvist R; Stattin P; Riboli E; Hallmans G; Kaaks R
    Ann Epidemiol; 2006 Jul; 16(7):563-71. PubMed ID: 16431135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
    Ahmed RL; Thomas W; Schmitz KH
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):593-7. PubMed ID: 17372257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.
    Heald AH; Kaushal K; Siddals KW; Rudenski AS; Anderson SG; Gibson JM
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):371-6. PubMed ID: 16915540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of IGF-1 and IGFBP-3 with lower urinary tract symptoms in the third national health and nutrition examination survey.
    Rohrmann S; Giovannucci E; Smit E; Platz EA
    Prostate; 2007 Nov; 67(15):1693-8. PubMed ID: 17879951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional and longitudinal associations between insulin-like growth factor I and metabolic syndrome: a general population study in German adults.
    Friedrich N; Nauck M; Schipf S; Völzke H; Brabant G; Wallaschofski H
    Diabetes Metab Res Rev; 2013 Sep; 29(6):452-62. PubMed ID: 23576494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
    Seino Y; Hirose H; Saito I; Itoh H
    Metabolism; 2007 Nov; 56(11):1493-9. PubMed ID: 17950099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.
    Sierra-Johnson J; Somers VK; Kuniyoshi FH; Garza CA; Isley WL; Gami AS; Lopez-Jimenez F
    Am J Cardiol; 2006 Nov; 98(10):1369-73. PubMed ID: 17134631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone.
    Ehrnborg C; Ohlsson C; Mohan S; Bengtsson BA; Rosén T
    Growth Horm IGF Res; 2007 Jun; 17(3):234-41. PubMed ID: 17347011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
    Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome?
    Ruan W; Lai M
    Acta Diabetol; 2010 Mar; 47(1):5-14. PubMed ID: 19771387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference values for serum levels of insulin-like growth factor (IGF-1) and IGF-binding protein 3 (IGFBP-3) and their ratio in Chinese adolescents.
    Kong AP; Wong GW; Choi KC; Ho CS; Chan MH; Lam CW; Tong PC; Ozaki R; So WY; Ma RC; Lau JT; Chan JC
    Clin Biochem; 2007 Oct; 40(15):1093-9. PubMed ID: 17673197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
    Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
    Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE
    Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.